Rare diseases
Investigational molecules
Locations
Back to Spain151 clinical trials in Caceres, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of ALX148 and Azacitidine for Untreated Higher Risk Myelodysplastic Syndrome Patients
SpainStudy on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors
SpainStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
SpainStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
SpainStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
SpainStudy on the Effects of Metoprolol, Prasugrel, and Carbasalate Calcium in Patients with Spontaneous Coronary Artery Dissection
SpainStudy on Reduced Antiplatelet Therapy with Acetylsalicylic Acid and Clopidogrel for Patients with Coronary Artery Disease After Stent Implantation
SpainStudy on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
SpainStudy Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
SpainStudy on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment
SpainStudy of Mosunetuzumab and Polatuzumab Vedotin Combination Treatment in Patients with B-Cell Non-Hodgkin Lymphoma
SpainStudy on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia and related blood disorders, evaluating novel therapeutic combinations and treatment approaches.
Studies include investigations of eganelisib, RVU120, and other promising compounds for refractory conditions.
Innovative trials examining treatments for coronary artery disease and related cardiovascular conditions, including specialized therapies for arterial dissection.
Research includes evaluation of novel medications and therapeutic approaches for various cardiac conditions.
Comprehensive research in breast cancer and melanoma, investigating targeted therapies and combination treatments for various cancer types.
Multiple trials exploring innovative treatment approaches for both early-stage and advanced cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
